PO-1108: SCRT and chemotherapy vs LCRT for unresectable rectal cancers. A propensity matchedpair analysis.

Saved in:
Bibliographic Details
Title: PO-1108: SCRT and chemotherapy vs LCRT for unresectable rectal cancers. A propensity matchedpair analysis.
Authors: Engineer, R. (AUTHOR), Saklani, A. (AUTHOR), D'souza, A. (AUTHOR), Mokal, S. (AUTHOR), Dhyani, A. (AUTHOR), Chopra, S. (AUTHOR)
Source: Radiotherapy & Oncology. 2020 Supplement 1, Vol. 152, pS585-S585. 1p.
Subjects: Rectal cancer, Cancer chemotherapy
Abstract: A propensity matchedpair analysis R. Engineer, A. Saklani, A. D'souza, S. Mokal, A. Dhyani, S. Chopra, Poster: Clinical track: Lower GI (colon, rectum, anus) PO-1108: SCRT and chemotherapy vs LCRT for unresectable rectal cancers. PO-1108: SCRT and chemotherapy vs LCRT for unresectable rectal cancers. [Extracted from the article]
Copyright of Radiotherapy & Oncology is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Engineering Source
Description
Abstract:A propensity matchedpair analysis R. Engineer, A. Saklani, A. D'souza, S. Mokal, A. Dhyani, S. Chopra, Poster: Clinical track: Lower GI (colon, rectum, anus) PO-1108: SCRT and chemotherapy vs LCRT for unresectable rectal cancers. PO-1108: SCRT and chemotherapy vs LCRT for unresectable rectal cancers. [Extracted from the article]
ISSN:01678140
DOI:10.1016/S0167-8140(21)01125-7